Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lux Capital
Biotech
Biotech veteran Robert Langer joins son launching new VC
The father and son duo Robert and Michael Langer want to back “visionary founders” at the intersection of technology and biology.
Zoey Becker
Sep 18, 2025 3:15pm
Eikon remains in megaround mode with $350M series D
Feb 26, 2025 9:40am
Enveda envisions clinical wins with $130M series C raise
Nov 21, 2024 10:55am
Mendaera grabs $73M for handheld, needle-based robotics system
Sep 27, 2024 11:30am
A new dimension: Biotech VC unveils with $350M
Jan 25, 2023 11:31am
Amgen-partnered Plexium snags $102M for protein degraders
Feb 23, 2022 8:00am
